Zevra Therapeutics, Inc.

NASDAQ:ZVRA

Biotechnology

Healthcare
$9.28 +2.44%

+$0.31 today

Market cap
$552.20M
Beta
0.89
P/E (TTM)
6.1
EPS (TTM)
$2.13
52W Low $7.16High $14.27

Volume 0.62M

Average 1.43M

Price history

Zevra Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-4.33%

Period high

$14.75

Period low

$8.10

Latest

$9.28

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 5, 2026Nov 5, 2026
10-QNov 3, 2026Nov 3, 2026
8-KNov 3, 2026Nov 3, 2026
4Oct 13, 2026Oct 13, 2026
4Aug 17, 2026Aug 17, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
4Aug 12, 2026Aug 12, 2026
SC 13G/AAug 6, 2026Aug 6, 2026
10-QAug 5, 2026Aug 5, 2026
8-KAug 5, 2026Aug 5, 2026
SC 13GJul 31, 2026Jul 31, 2026
4Jun 23, 2026Jun 23, 2026
4Jun 18, 2026Jun 18, 2026
4Jun 18, 2026Jun 18, 2026
4Jun 18, 2026Jun 18, 2026

Competitors

Who does Zevra Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ZVRA's filings, answered from its disclosures.

What is the latest ZVRA filing?

The latest filing shown is SC 13G/A dated Nov 5, 2026.

How many recent filings does ZVRA have?

Intrinsic Alpha currently shows 20 recent filings for ZVRA.